Skip to content

Epidermal Adhesive Sensors to Enhance Continuous Glucose Measurement in Patients With Diabetes: The EASE Study

Epidermal Adhesive Sensors to Enhance Continuous Glucose Measurement in Patients With Diabetes: The EASE Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04088201
Enrollment
50
Registered
2019-09-12
Start date
2019-09-26
Completion date
2021-06-30
Last updated
2020-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Brief summary

Self-testing of glucose by patients living with diabetes mellitus (DM) involves needles, which can cause discomfort or inconvenience; these and other factors can lead to decreased willingness to perform these checks that are vital to DM management. While technology has evolved, a needle-free glucose monitoring device is currently not available. The investigators are studying a glucose sensor that adheres to the skin, similarly to a temporary tattoo. This sensor can now obtain continuous readings. As it has not yet been tested in individuals with DM, this study will examine its accuracy and acceptability in these patients. Results from this clinical trial could serve as the basis for further development of a non-invasive, wearable glucose sensor that can provide measurements of glucose levels continuously.

Interventions

DEVICEGlucose measurements

We will not conduct an intervention, but will obtain measurements from a continuous, non-invasive glucose sensor, and compare with those from a glucometer.

Sponsors

University of California, San Diego
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* An existing diagnosis of diabetes mellitus, either T1DM or T2DM, or any other type or etiology of diabetes * Ability to provide informed consent for participation.

Exclusion criteria

* Individuals without diabetes * Those who cannot speak or read English. We are limiting participation to those who read and speak English, as this is a pilot study of a small number of participants, that will very unlikely offer the prospect of direct benefit from participating. * Individuals who have frequent hypoglycemia, hypoglycemia unawareness, or who are at high risk for hypoglycemia.

Design outcomes

Primary

MeasureTime frameDescription
Interstitial fluid glucose readingsHourly, up to 8 hoursNeedle-less measurements with an epidermal sensor - pls note, study is to assess how sensor readings compare with those from a glucometer

Secondary

MeasureTime frameDescription
Acceptablility of sensorAt end of study testing sessions, at 8 hoursWill survey pts

Countries

United States

Contacts

Primary ContactCarolyn Hernandez, BS
c1hernandez@health.ucsd.edu562-787-0951

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026